Align Technology | ALGN - Loan Capital

Stock Price
156.56
Daily Change
-2.22 -1.40%
Monthly
-18.31%
Yearly
-14.25%
Q2 Forecast
154.09

Align Technology reported $0 in Loan Capital for its fiscal quarter ending in December of 2024.





Loan Capital Change Date
3M USD 10.91B 26M Mar/2026
Align Technology USD 0 0 Dec/2024
Becton, Dickinson and Co. USD 14.71B 2.21B Mar/2026
Bruker USD 1.66B 189.6M Mar/2026
Cardinal Health USD 8.25B 102M Mar/2026
Charles River Laboratories USD 2.66B 526.77M Mar/2026
Cooper Companies USD 1.88B 578.5M Dec/2025
CVS Health USD 60.53B 29M Mar/2026
Danaher USD 17.56B 855M Mar/2026
Dentsply International USD 2.01B 9M Mar/2026
Dexcom USD 1.3B 54.4M Mar/2026
Henry Schein USD 2.33B 17M Mar/2026
Idexx Laboratories USD 299.85M 74.99M Mar/2026
Insulet USD 929.5M 1.3M Mar/2026
Integra LifeSciences USD 1.83B 29.45M Mar/2026
IQVIA Holdings USD 13.99B 105M Mar/2026
Masimo USD 445.7M 72.3M Mar/2026
McKesson USD 5.26B 166M Mar/2026
Mettler Toledo International USD 2.16B 73.35M Mar/2026
Revvity USD 2.63B 836K Mar/2026
Solventum Corp USD 4.58B 460M Mar/2026
Stryker USD 14.22B 635M Mar/2026
Teleflex USD 2.51B 27.18M Mar/2026
Thermo Fisher Scientific USD 40.07B 4.22B Mar/2026
Waters USD 5.22B 3.81B Mar/2026
Zimmer Biomet Holdings USD 6.3B 636.9M Mar/2026
Zoetis USD 9.04B 3M Mar/2026